Moody Aldrich Partners’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-28,768
Closed -$3.92M – 189
2020
Q3
$3.92M Buy
28,768
+7,089
+33% +$754K 0.82% 54
2020
Q2
$2.1M Buy
+21,679
New +$1.81M 0.45% 84

Moody Aldrich Partners's MYOK Position: Q4 2020 in Review

Moody Aldrich Partners sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 28,768 shares — an estimated $3.92M sold.

Moody Aldrich Partners first reported a position in MYOK in Q2 2020 and held it in 2 quarters. The position peaked at $3.92M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Moody Aldrich Partners reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Moody Aldrich Partners sold 28,768 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $3.92M.
  • Moody Aldrich Partners first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Moody Aldrich Partners's MyoKardia, Inc. Common Stock position peaked at $3.92M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Moody Aldrich Partners's 13F filing for Q4 2020, filed 16 Feb 2021.